TE_38952

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family THE1B
TE superfamily MaLR
TE class LTR
Gene -, ENSG00000291034
Class Chimeric, Intergenic
Coding Non-coding
Tumor-specific score 0.18
Counts of samples TCGA_tumor:73; TCGA_normal:6; GTEx:465
TSS chrY(-):12110027



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_38952.1 ENSG00000291034 Chimeric Non-coding Non-coding chrY(-):12089265,12089285,12089886,12089977,12098016,12098099,12109966,12110028
teRNA_38952.2 - Intergenic Non-coding Non-coding chrY(-):12051598,12051618,12055415,12055725,12109966,12110028
teRNA_38952.3 - Intergenic Non-coding Non-coding chrY(-):12089262,12089282,12098016,12098099,12108883,12108947,12109966,12110028
teRNA_38952.4 - Intergenic Non-coding Non-coding chrY(-):12089262,12089282,12098016,12098099,12106882,12107015,12109966,12110028


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).